14.15
price up icon4.58%   0.62
after-market After Hours: 13.92 -0.23 -1.63%
loading
Certara Inc stock is traded at $14.15, with a volume of 2.11M. It is up +4.58% in the last 24 hours and up +28.17% over the past month. Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$13.53
Open:
$13.56
24h Volume:
2.11M
Relative Volume:
1.22
Market Cap:
$2.33B
Revenue:
$363.55M
Net Income/Loss:
$-78.68M
P/E Ratio:
-28.30
EPS:
-0.5
Net Cash Flow:
$50.74M
1W Performance:
+34.63%
1M Performance:
+28.17%
6M Performance:
+22.30%
1Y Performance:
-16.52%
1-Day Range:
Value
$13.43
$14.17
1-Week Range:
Value
$11.44
$14.48
52-Week Range:
Value
$8.635
$17.94

Certara Inc Stock (CERT) Company Profile

Name
Name
Certara Inc
Name
Phone
(415) 237-8272
Name
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Name
Employee
1,546
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
CERT's Discussions on Twitter

Compare CERT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
CERT
Certara Inc
14.15 2.33B 363.55M -78.68M 50.74M -0.50
Health Information Services icon
VEEV
Veeva Systems Inc
215.95 36.39B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
53.21 9.87B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
40.45 7.46B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
84.52 7.21B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
36.45 6.30B 906.14M -52.62M 89.62M -0.3621

Certara Inc Stock (CERT) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-27-25 Initiated TD Cowen Buy
Sep-27-24 Upgrade UBS Neutral → Buy
Apr-10-24 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-04-24 Initiated JMP Securities Mkt Perform
Feb-26-24 Initiated Leerink Partners Market Perform
Dec-07-23 Initiated UBS Neutral
Dec-05-23 Initiated KeyBanc Capital Markets Sector Weight
Aug-22-23 Downgrade Jefferies Buy → Hold
Aug-10-23 Downgrade William Blair Outperform → Mkt Perform
Apr-12-23 Initiated Stephens Overweight
Apr-03-23 Downgrade Barclays Overweight → Equal Weight
Dec-14-22 Downgrade Robert W. Baird Outperform → Neutral
Sep-08-22 Initiated Berenberg Buy
Aug-25-22 Initiated Credit Suisse Outperform
Jul-01-22 Initiated Piper Sandler Overweight
Jan-11-22 Upgrade Jefferies Hold → Buy
Aug-05-21 Resumed Credit Suisse Neutral
Jul-23-21 Initiated Robert W. Baird Outperform
Mar-03-21 Initiated Barclays Overweight
Jan-06-21 Initiated Morgan Stanley Equal-Weight
Jan-05-21 Initiated BofA Securities Buy
Jan-05-21 Initiated Credit Suisse Neutral
Jan-05-21 Initiated Jefferies Hold
Jan-05-21 Initiated William Blair Outperform
View All

Certara Inc Stock (CERT) Latest News

pulisher
Apr 16, 2025

Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Certara Inc (CERT) Shares Gap Down to $13.69 on Apr 15 - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Certara expects Q1 sales above estimates - MSN

Apr 16, 2025
pulisher
Apr 15, 2025

Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st

Apr 15, 2025
pulisher
Apr 15, 2025

Certara (CERT) Exceeds Revenue Expectations with Strong Q1 Growt - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Why Certara Inc. (CERT) Soared Last Week? - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Why Certara Inc. (CERT) Skyrocketed On Monday? - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

Certara (CERT) Secures One-Year Lock-Up Agreement with Arsenal C - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara's Stock Soars on Strong Revenue Guidance and AI-Driven Innovations - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara launches Non-Animal Navigator for drug development By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Certara announces Q1 revenue growth and $100 million buyback By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Launches Product for Biopharmaceutical Firms to Reduce Reliance on Animal Testing - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Certara IncEntered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Certara launches Non-Animal Navigator for drug development - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

Certara (CERT) Introduces Non-Animal Navigator to Advance Precli - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara (CERT) Reaffirms 2025 Financial Projections | CERT Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Launches Non-Animal Navigator™ Solution to Help Drug Dev - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara's Preliminary Q1 Revenue Increases; Reiterates 2025 Outlook; Authorizes $100 Million Share Buyback Plan - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Certara (CERT) Reports Strong Growth in Q1 2024 Performance | CE - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Launches Non- Animal Navigator?? Solution to Help Drug Developers Reduce Reliance on Animal Testing - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Certara announces Q1 revenue growth and $100 million buyback - Investing.com

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

Certara Delivers Strong Q1: Software Revenue Surges 18%, Unveils Major Buyback Plan - Stock Titan

Apr 14, 2025
pulisher
Apr 13, 2025

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? - Benzinga

Apr 13, 2025
pulisher
Apr 13, 2025

Robert W. Baird Raises Certara (NASDAQ:CERT) Price Target to $13.00 - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

10 Firms Defy Market Slump, Record Double-Digit Gains Last Week - Insider Monkey

Apr 12, 2025
pulisher
Apr 12, 2025

Certara Inc (CERT) Shares Up 18.36% on Apr 11 - GuruFocus

Apr 12, 2025
pulisher
Apr 12, 2025

Certara (CERT) Receives Price Target Boost Following FDA Biosimu - GuruFocus

Apr 12, 2025
pulisher
Apr 12, 2025

Barclays Has Lowered Expectations for Certara (NASDAQ:CERT) Stock Price - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Certara (NASDAQ:CERT) Shares Gap Up After Analyst Upgrade - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Why Certara Inc. (CERT) Surged On Friday? - MSN

Apr 12, 2025
pulisher
Apr 11, 2025

Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks - Insider Monkey

Apr 11, 2025
pulisher
Apr 11, 2025

What Analysts Are Saying About Certara Stock - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Certara (CERT) Enhances Simcyp Simulator for Advanced Drug Devel - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Buy Certara After The FDA Announcement (NASDAQ:CERT) - Seeking Alpha

Apr 11, 2025
pulisher
Apr 11, 2025

Certara’s Stock: A Rapid Ascent - timothysykes.com

Apr 11, 2025
pulisher
Apr 11, 2025

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday? - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Apr 11, 2025
pulisher
Apr 11, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

After-Hour Gains Boost Certara Stock Following Continued Upward Momentum - Stocks Telegraph

Apr 11, 2025
pulisher
Apr 10, 2025

Certara (CERT) Stock Analysis: Is It Overvalued? - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Barclays Remains a Hold on Certara (CERT) - The Globe and Mail

Apr 10, 2025
pulisher
Apr 09, 2025

Certara, Inc. (NASDAQ:CERT) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Certara, Inc. (NASDAQ:CERT) Stock Holdings Lifted by Vanguard Group Inc. - Defense World

Apr 08, 2025

Certara Inc Stock (CERT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$25.75
price up icon 2.14%
$19.33
price up icon 0.05%
$23.68
price down icon 0.80%
$16.60
price down icon 1.25%
health_information_services WAY
$36.45
price down icon 0.71%
Cap:     |  Volume (24h):